Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00942708 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00942708 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT00942708, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will evaluate the safety, tolerability and efficacy of open-label fluoxetine for three months among patients with pulmonary arterial hypertension.
Interventions
- DRUG Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00942708
The ClinicalTrials.gov registry entry for NCT00942708 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluoxetine is the first listed.
NCT00942708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00942708 about?
NCT00942708 is a clinical study titled "Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension". This study will evaluate the safety, tolerability and efficacy of open-label fluoxetine for three months among patients with pulmonary arterial hypertension.
What is the current status of trial NCT00942708?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2009-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00942708?
The interventions under investigation include: Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00942708?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.